Clinical Trials Sponsored by Core Medical (Beijing) Co., Ltd.

Total 1732 results

Eucure (Beijing) Biopharma Co., Ltd

Recruiting

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Advanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin Lymphoma

China
Eucure (Beijing) Biopharma Co., Ltd

Recruiting

A Study to Assess YH003 in Combination With Pebolizumab and Albumin Paclitaxel Injection in Subjects With Unresectable/Metastatic Mucosal Melanoma

Mucosal Melanoma

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Diabetes
Beijing Continent Pharmaceutical Co, Ltd.

Not yet recruiting

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

Pneumoconiosis
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Recruiting

Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

ANCA-associated Vasculitis

China
FutureGen Biopharmaceutical (Beijing) Co., Ltd

Recruiting

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Advanced Unresectable Solid Tumors

China
Beijing Mabworks Biotech Co., Ltd.

Recruiting

A Clinical Study of MIL95 in Advanced Malignancies.

Advanced Malignancies

China
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Renal Insufficiency

China
Beijing Doing Biomedical Co., Ltd.

Not yet recruiting

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

Lymphoma | Leukemia

China
Adai Technology (Beijing) Co., Ltd.

Completed

Game-Based Digital Intervention for Relieving Depression and Anxiety Symptoms

Depression | Anxiety

China
Eucure (Beijing) Biopharma Co., Ltd

Completed

Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy

Cancer

Australia
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
Beijing Suncadia Pharmaceuticals Co., Ltd

Active, not recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

Prevention of Arterial and Venous Thrombosis

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

F573 Ia Clinical Trial

Tolerance | Pharmacokinetic

China
Beijing Konruns Pharmaceutical Co., Ltd.

Completed

The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease

Chronic Pelvic Pain

China
Beijing Continent Pharmaceutical Co, Ltd.

Terminated

A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.

Radiation-induced Lung Injury

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Study on Pharmacokinetics of Hydronidone

Pharmacokinetics of Hydronidone

China
Beijing Northland Biotech. Co., Ltd.

Completed

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

Chemotherapy-induced Thrombocytopenia

China
Beijing Dongfang Biotech Co., Ltd.

Completed

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

Diabetes Mellitus, Type 2

China
Beijing Northland Biotech. Co., Ltd.

Completed

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003CLI-II)

Ischemia | Peripheral Vascular Disease | Arterial Occlusive Disease | Ulcers

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Safety and Efficacy of γδ T Cell Against Gastric Cancer

Gastric Cancer

China
Beijing Continent Pharmaceutical Co, Ltd.

Completed

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Hydronidone

China
Beijing Doing Biomedical Co., Ltd.

Unknown

Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.

Gastric Cancer

China
Beijing Viroad Biotechnology Co., Ltd.

Unknown

The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device

Circulating Tumor Cells.Breast

China
Beijing Dongfang Biotech Co., Ltd.

Unknown

a Study of JY09 in Chinese Healthy Subjects

Healthy
Beijing Biohealthcare Biotechnology Co.,Ltd

Unknown

Pilot Study of Anti-CD20-CAR-engineered T Cells in Patients With Chemotherapy Resistant or Refractory CD20+ Lymphoma

Lymphoma, B-Cell

China
Beijing Minhai Biotechnology Co., Ltd

Completed

Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine

Meningitis

China
Beijing Immunochina Medical Science & Technology...
Jiangsu Simcere Pharmaceutical Co., Ltd.

Recruiting

Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients

NHL

China
Henan Cancer Hospital
Kingbio Medical (Beijing) Co., Ltd.

Recruiting

Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer

Small Cell Lung Cancer

China
Beijing Mabworks Biotech Co., Ltd.
Betta Pharmaceuticals Co., Ltd.

Completed

mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Henan Cancer Hospital
Kingbio Medical (Beijing) Co., Ltd.

Recruiting

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

China
BrosMed Medical Co., Ltd
CCRF Inc., Beijing, China

Unknown

Study Evaluating the Safety and Efficacy of Tri-wire Balloon for Treatment of Dysfunctional AV Fistula

Arteriovenous Fistula

China
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Not yet recruiting

Computerized Cognitive Training to Protect Cognitive Function Among Hypertension Patients

Hypertension | Mild Cognitive Impairment

China
Geneplus-Beijing Co. Ltd.
Army Medical University, China

Recruiting

ctDNA Monitoring in Early Breast Cancer

Breast Cancer

China
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Active, not recruiting

Computerized Cognitive Training in Patients With Coronary Heart Disease and Mild Cognitive Impairment (COG-T CHD)

Coronary Heart Disease | Mild Cognitive Impairment

China
Xuanwu Hospital, Beijing
ChosenMed Technology (Beijing) Co.,Ltd

Unknown

Cancer Genome Atlas of China:Lung Cancer

Non-small Cell Lung Cancer

China
Beijing Tongren Hospital
Beijing Winsunny Pharmceutical Co.,Ltd.

Completed

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Obsessive-Compulsive Disorder | Generalized Anxiety Disorder | Major Depressive Disorder | Social Anxiety Disorder | Panic Disorder

China
Beijing Anzhen Hospital
Beijing Wispirit Technology Co., Ltd

Completed

Atrial Fibrillation Follow-up Investigation to Recover Memory and learnING Trial (AFFIRMING)

Cognitive Impairment | Atrial Fibrillation

China
Beijing Friendship Hospital
Newish Technology (Beijing) Co., Ltd.

Unknown

Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

China
Xijing Hospital of Digestive Diseases
Beijing Tide Pharmaceutical Co., Ltd

Completed

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

Esophageal Neoplasms

China
Xijing Hospital
Beijing GD Initiative Cell Therapy Technology Co., Ltd.

Not yet recruiting

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Melanoma
Beijing Kanova Biopharmaceutical Co., LTD

Active, not recruiting

Phase I of XKH001Injection in Healthy Adults

Healthy Adults

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Chronic Primary Immune Thrombocytopenia (ITP)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject

Hepatic Impairment

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (ICC)

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations

Advanced Solid Tumor

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

China
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Study of ICP-192 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Cholangiocarcinoma | Urothelial Carcinoma

Australia, United States

Clinical Trials Sponsored by Core Medical (Beijing) Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations